Detect the Undetected: Sotera Wireless Launches ViSi Mobile 1.5G with Arrhythmia and Fall Capabilities for Early Detection and Intervention

SAN DIEGO--(BUSINESS WIRE)-- Sotera Wireless, maker of the ViSi Mobile® Surveillance Monitoring System and a pioneer in continuous vital signs monitoring, announces the availability of its FDA-cleared Life-Threatening Arrhythmia and Atrial-Fibrillation (LTAA) and Fall Detection capabilities with the official launch of ViSi Mobile 1.5G. Previously cleared to monitor continuous noninvasive blood pressure (cNIBP), functional oxygen saturation of arterial hemoglobin (SpO2), heart rate, pulse rate, ECG activity, respiration rate and skin temperature in hospital-based facilities, ViSi Mobile 1.5G now includes atrial fibrillation, ventricular fibrillation, ventricular tachycardia, and asystole analysis and alarming along with many other enhancements.

According to the Centers for Disease Control and Prevention, atrial fibrillation, an abnormal heart rhythm or “arrhythmia” in which the upper chambers of the heart contract irregularly and inefficiently, affects 2.7-6.1 million Americans¹. Often asymptomatic, atrial fibrillation may remain undiagnosed until or even after development of complications, such as stroke. Post-operative atrial fibrillation is the most common arrhythmia that occurs after both cardiac and noncardiac surgery and is associated with an increased morbidity, longer hospital stays and higher hospital costs².

ViSi Mobile 1.5G was also FDA-cleared to track and alarm for patient posture and fall events which can alert medical personnel to undesirable patient positions, patient immobility, and patient falls as well as display patient movement and posture (stationary, reclined, lying-down or walking). The Agency for Healthcare Research and Quality estimates that 700,000 to 1 million hospitalized patients fall each year³, resulting in significant cost burden to healthcare providers.

About Sotera Wireless

Sotera Wireless, Inc. is a San Diego-based company committed to the development, marketing and sale of a new generation early detection surveillance monitoring system. Its flagship product, the ViSi Mobile, is designed to improve patient safety by detecting early signs of deterioration in virtually any care setting, enabling early intervention and rapid response without limiting the patient’s freedom of movement. More information on the Company or ViSi Mobile can be obtained at soterawireless.com.

Sotera® and ViSi Mobile® are registered trademarks of Sotera Wireless, Inc.

¹ Centers for Disease Control and Prevention. Atrial Fibrillation Fact Sheet. Updated August 22, 2017.
² https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771807/
³ https://psnet.ahrq.gov/primers/primer/40/Falls

View source version on businesswire.com: https://www.businesswire.com/news/home/20190305005032/en/